KEYNOTE-564 follow-up shows OS and DFS gains with adjuvant pembrolizumab in high-risk ccRCC, plus guidance on relapse after therapy. In the adjuvant setting, managing the patient with high-risk clear ...
First line treatment of pancreatic metastases in metastatic renal cell carcinoma: Insights from the UK Renal Oncology Collaborative (UK ROC)—Tyrosine kinase inhibitors time to shine? This is an ASCO ...
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults COSMIC 313 was a phase III, double-blind trial, that randomly assigned treatment-naïve ...
CHICAGO -- Clinical activity and survival outcomes improved with the addition of ipilimumab (Yervoy) to nivolumab (Opdivo) in patients with ovarian or other gynecologic clear cell carcinomas, ...
ITM-94, a gallium-68-radiolabeled PET imaging agent, targets carbonic anhydrase IX, crucial in tumor growth and metastasis. The FDA's fast track designation aims to expedite ITM-94's development for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results